Defunct Company
Total Trials
6
As Lead Sponsor
5
As Collaborator
1
Total Enrollment
770
NCT02667054
Topical Anesthetic for Procedures Through the Nose
Phase: Phase 3
Role: Lead Sponsor
Start: Sep 30, 2014
Completion: Jan 31, 2016
NCT02667106
Phase I Pharmacokinetic Study of RX0041-2
Phase: Phase 1
Start: Oct 31, 2015
Completion: Oct 31, 2015
NCT02775955
PK Study of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Normal Renal Function
Start: Feb 29, 2016
Completion: Oct 31, 2016
NCT02775981
Pharmacokinetic Study of Intranasal RX0041-002 in Hepatic-Impaired Individuals and Subjects With Normal Hepatic Function
Completion: Sep 30, 2016
NCT04792034
Pharmacokinetics, Safety, and Tolerability Study of GOPRELTO® Nasal Solution
Phase: Phase 4
Start: Apr 1, 2021
Completion: Dec 1, 2021
NCT04226690
Safety and Effects on Responses to Stress and Pain of Natural Medical Marijuana Products
Role: Collaborator
Start: Nov 15, 2022
Completion: Dec 15, 2023